{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-010484","form_type":"8-K","ticker":"CYDY","cik":"0001175680","company_name":"CytoDyn Inc.","filed_at":"2022-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.945548+00:00","generated_at":"2026-06-24T21:54:29.767711+00:00","sec_items":["3.02","5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CytoDyn raises $21.8M in private placement; appoints Cyrus Arman as President","bullets":["Raised ~$21.8M gross via ~85.4M units at $0.255/unit; each unit = 1 share + 3/4 warrant (5-yr term).","Cyrus Arman, Ph.D. appointed President effective July 9, 2022; replaces interim President Migliarese who stays CFO.","Arman's base salary $458K, target bonus 40%, equity grants (options $750K, RSUs/PSUs $375K) subject to shareholder vote.","Placement agent receives 13% cash fee + ~19.4M warrants (10-yr) subject to shareholder approval of authorized share increase.","Issued 43,657 shares to former executive for severance obligation of $15,523."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-010484","json":"https://secwatch.observer/filing/0001558370-22-010484.json","markdown":"https://secwatch.observer/filing/0001558370-22-010484.md","text":"https://secwatch.observer/filing/0001558370-22-010484.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/cydy-20220624x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T21:54:29.767711+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3281e40a4c","claim":"Antonio Migliarese changed role as Chief Financial Officer, Corporate Secretary and Treasurer at CytoDyn Inc..","evidence_excerpt":"Antonio Migliarese, who was appointed as interim President on January 24, 2022, will cease to be President on July 9, 2022, but will continue in his roles of Chief Financial Officer, Corporate Secretary and Treasurer, as well as serving as the Company’s principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"ceased to be President"},{"label":"Role","value":"Chief Financial Officer, Corporate Secretary and Treasurer"}],"fact_type":"executive_change"},{"claim_id":"62cd76f951","claim":"Cyrus Arman was appointed as President at CytoDyn Inc..","evidence_excerpt":"entered into an employment agreement with Cyrus Arman, Ph.D. (the “Employment Agreement”), under which he will be employed as the Company’s President on an at-will basis beginning on July 9, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175680/000155837022010484/0001558370-22-010484-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}